Retraction notice to "The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway" [Journal of Molecular and Cellular Cardiology 187 (2023) 26-37].

IF 4.9 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of molecular and cellular cardiology Pub Date : 2024-11-16 DOI:10.1016/j.yjmcc.2024.09.009

Xuemei Wang, Hao Wu, Luxun Tang, Wenbin Fu, Yanji He, Chunyu Zeng, Wei Eric Wang

引用次数: 0

查看原文本刊更多论文

新型抗体融合蛋白 rhNRG1-HER3i 通过增强 NRG1-ERBB4 信号通路促进心脏再生》[《分子和细胞心脏病学杂志》187 (2023) 26-37] 撤稿通知。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of molecular and cellular cardiology 医学-细胞生物学

CiteScore

10.70

自引率

0.00%

发文量

171

审稿时长

42 days

期刊介绍： The Journal of Molecular and Cellular Cardiology publishes work advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function. To this end papers are published in all relevant areas. These include (but are not limited to): structural biology; genetics; proteomics; morphology; stem cells; molecular biology; metabolism; biophysics; bioengineering; computational modeling and systems analysis; electrophysiology; pharmacology and physiology. Papers are encouraged with both basic and translational approaches. The journal is directed not only to basic scientists but also to clinical cardiologists who wish to follow the rapidly advancing frontiers of basic knowledge of the heart and circulation.